Cellogen Therapeutics secures patent for India’s first Bi-Specific CAR T Cell therapy
Regulatory approval paves the way for advanced cancer immunotherapy in India
Recover your password.
A password will be e-mailed to you.
- Advertisement -
- Advertisement -
Recover your password.
A password will be e-mailed to you.